Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
FibriCheck’s smartphone-based, medically certified app uses PPG technology and AI algorithms to detect and monitor cardiac arrhythmias, including atrial fibrillation. It is FDA-cleared, CE-marked, ISO 13485 certified, and has demonstrated high sensitivity (>98%) and specificity (>99%) in clinical studies. The solution supports remote patient monitoring with actionable insights for healthcare providers. Over 75 published studies feature the product; it is integrated into multiple clinical pathways across Europe and the US.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on FibriCheck.